JNK is activated by hyperglycemia and free fatty acids, promoting cardiomyocyte apoptosis and interfering with insulin receptor substrate-1 (IRS-1) signaling, thus suppressing PI3K/Akt activity. Here, AKT1 is linked to Hyperglycemia.